Bishal Gyawali, MD, PhD, FASCO

@oncology_bg

Personal acc. Med Onc. A/Prof. @queensoncology @QueensuPHS. #cancerpolicy #cancergroundshot. Pubs: http://tinyurl.com/oncobg Talks- http://tinyurl.com/mrprevnp

Kingston, Ontario

Joined September 2015

819Following

16KFollowers

Pinned

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 4

This @oncodaily article is so well written that I almost felt like I learned something new about myself! Wonderful writing/editing skills @VaheGrigo! oncodaily.com/oncolibrary/on…

oncology_bg's tweet image. This @oncodaily article is so well written that I almost felt like I learned something new about myself! Wonderful writing/editing skills @VaheGrigo!

oncodaily.com/oncolibrary/on…

4.0K

Pinned

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 26

Agree 💯. These shouldn’t be controversial. These are just common sense.

IIan Davis (Bluesky @profiand)@Prof_IanD · Jul 26

Two opinions that to my surprise are either unpopular or not widely held: 1. The control arm of a randomised trial should be best standard of care. 2. A PFS benefit against an inactive comparator is not a major advance, if progressive disease is required for eligibility.

1.0K

Bishal Gyawali, MD, PhD, FASCO Retweeted

Crying Wolf@OncologyCompany · 14 h

A “promising drug” is not good enough to market in a civilized society. A drug that “could work” remains half-backed. I like my drugs proven. Not theoretical.

401

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 25

Something that I really really don’t feel comfortable doing but something I always feel glad that I did it anyway- Calling the family of my patients after they have passed away. It’s not easy, but please call. It’s the least we can do.

1.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 23

Public gym by the Bondi beach. Any health system that has money to fund drugs like neratinib and regorafenib but doesn’t invest in such public gyms is not common sense. I have seen only very few of these in Canada. We need more!

1.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 23

The world deserves to know what Meta AI thinks about @DKarikios 😂

462

Bishal Gyawali, MD, PhD, FASCO Retweeted

JAMA Oncology@JAMAOnc · Jul 23

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4m3Eesv @AlexSherryMD @oncology_bg @PavlosMsaouel @ebludmir

4.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 23

"Many lives are lost not because they don't have access to newest technology or drugs, but because they didn't receive proven treatments in time" @oncology_bg wonderful to meet you @ANZUPtrials #anzup25 #CommonSenseOncology

BBishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

Thank you @ANZUPtrials @Prof_IanD @doccharris @DrL_Krieger for the invitation to share my thoughts with the ANZUP audience and for such a warm hospitality. Had a fabulous time, met new colleagues, built foundations for new collaborations, and hopefully for better outcomes for our…

3.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

Thank you #ANZUP25 family for specially appreciating my jokes. I will tell my wife and kids back home that in some part of the world people still find me funny.

870

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

Thank you, Ian. You have always been a role model- we look up to you (and Anzup) as the examples of how clinical trials and industry collaborations can be done the right way. Looking forward to all other amazing results that’ll come out of Anzup family in days to come.

IIan Davis (Bluesky @profiand)@Prof_IanD · Jul 22

It was fantastic to have you with us! Thanks for your enthusiastic participation and thought-provoking and entertaining presentations. I know you are seen as a role model by many (including me) and that you will have influenced many people at #ANZUP25, by both words and actions.

1.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

oncology_bg's tweet image. Thank you @ANZUPtrials @Prof_IanD @doccharris @DrL_Krieger for the invitation to share my thoughts with the ANZUP audience and for such a warm hospitality. Had a fabulous time, met new colleagues, built foundations for new collaborations, and hopefully for better outcomes for our…

4.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

From outcomes that matter to currencies that matter. #ANZUP25 @ANZUPtrials

981

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 22

Check it out for my absolutely “nothing to do with oncology” book recommendations.

PPaolo Tarantino@PTarantinoMD · Jul 21

Which books do oncologists say their peers should read this summer? Loved to contribute to this project, alongside amazing colleagues! oncologynewscentral.com/experience/boo…

3.0K

Bishal Gyawali, MD, PhD, FASCO Retweeted

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 7

Hello my friends and colleagues in Australia and New Zealand. I’ll be at #ANZUP25 Annual Meeting in Sydney doing these 3 talks. Come say hi if you’re around! anzup.org.au/asm2025/

4.0K

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 21

Very interesting readers' comments on this piece. Do board exams make us better doctors? medscape.com/viewarticle/do…

946

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 21

Really enjoyed this talk!

TTian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)@TiansterZhang · Jul 21

@ChrisSweens1 with comprehensive landscape talk in only 5 mins (!!), highlighting the #DASLHiCAP darolutamide role for high risk #prostatecancer. Pending further follow up. @ANZUPtrials #ANZUP25

1.0K

Bishal Gyawali, MD, PhD, FASCO Retweeted

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)@TiansterZhang · Jul 21

Correlative work is possibly our most important tool in clinical trials. Congrats to @EdmondMKwan & #TheraP team for this insightful pub on ctDNA burden & PTEN loss predicting responses to 177Lu-PSMA & reminding us of his why - the patients behind the data. @ANZUPtrials #ANZUP25

2.0K

Bishal Gyawali, MD, PhD, FASCO Retweeted

DrAndrewWeickhardt@WeickhardtOnc · Jul 21

Media hype, bad headlines & euphemisms mask trial truths. @oncology_bg calls for honesty in trials, press, and the clinic. #CommonSenseOncology is needed #ANZUP25 #EndOfLifeCare

653

Bishal Gyawali, MD, PhD, FASCO Retweeted

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)@TiansterZhang · Jul 21

@LouiseEmmett giving updates of #ENZAP & #EVOLUTION trials — such important IITs to help us understand ideal use of 177Lu-PSMA in met #prostatecancer. Congrats to all within @ANZUPtrials who contributed to these trials! #ANZUP25

2.0K

Bishal Gyawali, MD, PhD, FASCO Retweeted

Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)@TiansterZhang · Jul 21

@UrogerliMD @MoffittNews with eloquent discussion of importance for multiD care & communication now that systemic therapies coming into landscape for localized #bladdercancer. Highlighting CREST sasanlimab & SUNRISE TAR-200 trials. #ANZUP25 @ANZUPtrials

858

Bishal Gyawali, MD, PhD, FASCO@oncology_bg · Jul 20

Thank you so much for having me. I enjoyed preparing for and giving this talk. I hope the audience found it meaningful. 🙏🙏

IIan Davis (Bluesky @profiand)@Prof_IanD · Jul 20

@oncology_bg gives an engaging, hilarious, and deeply thought-provoking talk on common sense communication in @ANZUPtrials #ANZUP25 opening plenary session on “Connecting with big ideas.”

2.0K